Runt-related transcription factor 1 contributes to lung cancer development by binding to tartrate-resistant acid phosphatase 5

References

• Hirsch FR, Scagliotti GV, Mulshine JL, et al. Lung cancer: current therapies and new targeted treatments. Lancet. 2017;389:299–311.
   PubMed Web of Science ®Google Scholar
• Yoon SM, Shaikh T, Hallman M. Therapeutic management options for stage III non-small cell lung cancer. World J Clin Oncol. 2017;8:1–20.
   PubMed Web of Science ®Google Scholar
• Bach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012;307:2418–2429.
   PubMed Web of Science ®Google Scholar
• Reck M, Popat S, Reinmuth N, et al. Metastatic non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(Suppl 3):iii27–39.
   PubMed Web of Science ®Google Scholar
• Mao Y, Yang D, He J, et al. Epidemiology of Lung Cancer. Surg Oncol Clin N Am. 2016;25:439–445.
   PubMed Web of Science ®Google Scholar
• Lemjabbar-Alaoui H, Hassan OU, Yang YW, et al. Lung cancer: biology and treatment options. Biochim Biophys Acta. 2015;1856:189–210.
   PubMed Web of Science ®Google Scholar
• Vlachogeorgos GS, Manali ED, Blana E, et al. Placental isoform glutathione S-transferase and P-glycoprotein expression in advanced nonsmall cell lung cancer: association with response to treatment and survival. Cancer. 2008;114:519–526.
   PubMed Web of Science ®Google Scholar
• Haley KJ, Lasky-Su J, Manoli SE, et al. RUNX transcription factors: association with pediatric asthma and modulated by maternal smoking. Am J Physiol Lung Cell Mol Physiol. 2011;301:L693–701.
   PubMed Web of Science ®Google Scholar
• Khan M, Cortes J, Kadia T, et al. Clinical outcomes and Co-occurring mutations in patients with RUNX1-mutated acute myeloid leukemia. Int J Mol Sci. 2017;18:1618.
   Web of Science ®Google Scholar
• Tang X, Sun L, Jin X, et al. Runt-related transcription factor 1 regulates LPS-induced acute lung injury via NF-kappaB signaling. Am J Respir Cell Mol Biol. 2017;57:174–183.
   PubMed Web of Science ®Google Scholar
• Halling Linder C, Ek-Rylander B, Krumpel M, et al. Bone alkaline phosphatase and tartrate-resistant acid phosphatase: potential Co-regulators of bone mineralization. Calcif Tissue Int. 2017;101:92–101.
   PubMed Web of Science ®Google Scholar
• Gao YL, Liu MR, Yang SX, et al. Prognostic significance of ACP5 expression in patients with lung adenocarcinoma. Clin Respir J. 2018;12:1100–1105.
   PubMed Web of Science ®Google Scholar
• Jiang M, Zhou LY, Xu N, et al. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways. Thorac Cancer. 2019;10:1319–1333.
   PubMed Web of Science ®Google Scholar
• Boucherat O, Landry-Truchon K, Aoidi R, et al. Lung development requires an active ERK/MAPK pathway in the lung mesenchyme. Dev Dyn. 2017;246:72–82.
   PubMed Web of Science ®Google Scholar
• Wang L, Brugge JS, Janes KA. Intersection of FOXO- and RUNX1-mediated gene expression programs in single breast epithelial cells during morphogenesis and tumor progression. Proc Natl Acad Sci U S A. 2011;108:E803–12.
   PubMed Web of Science ®Google Scholar
• Zhang S, Chen S, Liu A, et al. Inhibition of BDNF production by MPP(+) through up-regulation of miR-210-3p contributes to dopaminergic neuron damage in MPTP model. Neurosci Lett. 2018;675:133–139.
   PubMed Web of Science ®Google Scholar
• Xu T, Niu C, Zhang X, et al. beta-Ecdysterone protects SH-SY5Y cells against beta-amyloid-induced apoptosis via c-Jun N-terminal kinase- and Akt-associated complementary pathways. Lab Invest. 2018;98:489–499.
   PubMed Web of Science ®Google Scholar
• Ji Y, Han Z, Shao L, et al. Evaluation of in vivo antitumor effects of low-frequency ultrasound-mediated miRNA-133a microbubble delivery in breast cancer. Cancer Med. 2016;5:2534–2543.
   PubMed Web of Science ®Google Scholar
• Huang C, Liu W, Perry CN, et al. Autophagy and protein kinase C are required for cardioprotection by sulfaphenazole. Am J Physiol Heart Circ Physiol. 2010;298:H570–9.
   PubMed Web of Science ®Google Scholar
• Yoo JJ, Lee JH, Lee SH, et al. Comparison of the effects of transarterial chemoembolization for advanced hepatocellular carcinoma between patients with and without extrahepatic metastases. PLoS One. 2014;9:e113926.
   PubMed Web of Science ®Google Scholar
• Leng F, Saxena L, Hoang N, et al. Proliferating cell nuclear antigen interacts with the CRL4 ubiquitin ligase subunit CDT2 in DNA synthesis-induced degradation of CDT1. J Biol Chem. 2018;293:18879–18889.
   PubMed Web of Science ®Google Scholar
• Wu L, Wang P. Long non-coding RNA-neighboring enhancer of FOXA2 inhibits the migration and invasion of small cell lung carcinoma cells by downregulating transforming growth factor-beta1. Oncol Lett. 2019;17:4969–4975.
   PubMed Web of Science ®Google Scholar
• Cao Q, Mao ZD, Shi YJ, et al. MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway. Oncotarget. 2016;7:77468–77481.
   PubMedGoogle Scholar
• Lv B, Huo F, Dang X, et al. Puerarin attenuates N-methyl-D-aspartic acid-induced apoptosis and retinal ganglion cell damage through the JNK/p38 MAPK pathway. J Glaucoma. 2016;25:e792–801.
   PubMed Web of Science ®Google Scholar
• Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62:220–241.
   PubMed Web of Science ®Google Scholar
• Li C, Lyu J, Meng QH. MiR-93 promotes tumorigenesis and metastasis of non-small cell lung cancer cells by activating the PI3K/Akt pathway via inhibition of LKB1/PTEN/CDKN1A. J Cancer. 2017;8:870–879.
   PubMed Web of Science ®Google Scholar
• Yao NS, Wu YY, Janckila AJ, et al. Serum tartrate-resistant acid phosphatase 5b (TRACP5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patients. Clin Chim Acta. 2011;412:181–185.
   PubMed Web of Science ®Google Scholar
• Xia L, Huang W, Tian D, et al. ACP5, a direct transcriptional target of FoxM1, promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma. Oncogene. 2014;33:1395–1406.
   PubMed Web of Science ®Google Scholar
• Lee JS, Jung WK, Jeong MH, et al. Sanguinarine induces apoptosis of HT-29 human colon cancer cells via the regulation of Bax/Bcl-2 ratio and caspase-9-dependent pathway. Int J Toxicol. 2012;31:70–77.
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhang HY, Pang YK, et al. [Knockdown of Puma protects cord blood CD34(+) cells against gamma- irradiation]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014;22:412–420.
   PubMedGoogle Scholar
• Liu CJ, Zhang XL, Luo DY, et al. Exogenous p53 upregulated modulator of apoptosis (PUMA) decreases growth of lung cancer A549 cells. Asian Pac J Cancer Prev. 2015;16:741–746.
   PubMedGoogle Scholar
• Scott KL, Nogueira C, Heffernan TP, et al. Proinvasion metastasis drivers in early-stage melanoma are oncogenes. Cancer Cell. 2011;20:92–103.
   PubMed Web of Science ®Google Scholar
• Kayed H, Jiang X, Keleg S, et al. Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancer. Br J Cancer. 2007;97:1106–1115.
   PubMed Web of Science ®Google Scholar
• Kara M, Yumrutas O, Ozcan O, et al. Differential expressions of cancer-associated genes and their regulatory miRNAs in colorectal carcinoma. Gene. 2015;567:81–86.
   PubMed Web of Science ®Google Scholar
• Slattery ML, Lundgreen A, Herrick JS, et al. Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and riskof colon and rectal cancer: additional support for a TGF-beta-signaling pathway. Carcinogenesis. 2011;32:318–326.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhang X, Zhang J, et al. LRG1 promotes proliferation and inhibits apoptosis in colorectal cancer cells via RUNX1 activation. PLoS One. 2017;12:e0175122.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhao Y, Qian H, et al. The miR-101/RUNX1 feedback regulatory loop modulates chemo-sensitivity and invasion in human lung cancer. Int J Clin Exp Med. 2015;8:15030–15042.
   PubMed Web of Science ®Google Scholar
• Taylor CA, Zheng Q, Liu Z, et al. Role of p38 and JNK MAPK signaling pathways and tumor suppressor p53 on induction of apoptosis in response to Ad-eIF5A1 in A549 lung cancer cells. Mol Cancer. 2013;12:35.
   PubMed Web of Science ®Google Scholar
• Tai YT, Landesman Y, Acharya C, et al. CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications. Leukemia. 2014;28:155–165.
   PubMed Web of Science ®Google Scholar
• Oren M. Decision making by p53: life, death and cancer. Cell Death Differ. 2003;10:431–442.
   PubMed Web of Science ®Google Scholar
• Wu D, Ozaki T, Yoshihara Y, et al. Runt-related transcription factor 1 (RUNX1) stimulates tumor suppressor p53 protein in response to DNA damage through complex formation and acetylation. J Biol Chem. 2013;288:1353–1364.
   PubMed Web of Science ®Google Scholar
• Yang L, Zhou Y, Li Y, et al. Mutations of p53 and KRAS activate NF-kappaB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells. Cancer Lett. 2015;357:520–526.
   PubMed Web of Science ®Google Scholar